Stimulant therapy and seizure risk in children with ADHD.
about
Utility of the Electroencephalogram in Attention Deficit Hyperactivity DisorderEpilepsy and attention-deficit hyperactivity disorder: links, risks, and challengesSafety of stimulant treatment in attention deficit hyperactivity disorder: part II.Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsComparing stimulant effects in youth with ADHD symptoms and epilepsyMethylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefitEuropean guidelines on managing adverse effects of medication for ADHD.Childhood epilepsy in relation to mental handicap and behavioural disorders.Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.Atypical presentations of benign childhood epilepsy with centrotemporal spikes: a review.Stimulant use in patients with sturge-weber syndrome: safety and efficacy.Therapy for neurobehavioral disorders in epilepsy.The challenge of neuropsychiatric issues in pediatric epilepsy.Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.Role of electroencephalography in attention-deficit hyperactivity disorder.Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.Spectrum of attention deficit hyperactivity disorders (ADHD) among Sudanese children with epilepsy.Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities."All that spikes is not fits", mistaking the woods for the trees: the interictal spikes--an "EEG chameleon" in the interface disorders of brain and mind: a critical review.Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment.The diagnosis and treatment of attention deficit hyperactivity disorder in patients with epilepsy.Clinical Impact of Epileptiform Discharge in Children With Attention-Deficit/Hyperactivity Disorder (ADHD).Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy.Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.Attention deficits and subclinical epileptiform discharges: are EEG diagnostics in ADHD optional or essential?Epilepsy in patients with autism: links, risks and treatment challenges.The effects of risk factors on EEG and seizure in children with ADHD.ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.When Is EEG Indicated in Attention-Deficit/Hyperactivity Disorder?Frequency of epileptiform discharges in the sleep-deprived electroencephalogram in children evaluated for attention-deficit disorders.Clinical observations on attention-deficit hyperactivity disorder (ADHD) in children with frontal lobe epilepsy.Attention-deficit/hyperactivity disorder medication and seizures.
P2860
Q22241782-CA43DE18-8DF7-4BB6-81ED-65219537D32EQ26765320-309944ED-F559-4042-A511-10E6F6512846Q30451303-3E6713FC-ABDF-49DC-80FC-AE81873FBABCQ33746664-F7B354C7-B0C4-417E-BF43-9E703DD2274BQ33944635-FAA572A1-FFE5-495D-A110-533F3517285DQ34402618-C6E14852-EC62-4C70-8906-78A8FC933A7EQ34448884-140EE2BC-D9AE-4E5B-8614-713D5C0C883CQ34540188-BDE6EF0C-C5F5-49BB-BA46-F355C17476EFQ34553650-6A285E88-B932-4BA9-BB54-378FAAFEEA1CQ34801535-29298D49-9843-4240-9969-BFF0593945EEQ35357653-051745AA-09E3-493D-B4CD-158B876DEB79Q35798249-99A2F579-5453-4079-8A3B-2921B2DBFB55Q35939575-AB649F21-091E-47D1-96E1-D1E12DE5B9B1Q36453293-23DE3D3A-2A4D-4BFF-BB9C-19130E7660FDQ36492366-ED92CB7A-0EAE-43FC-B4F7-A3014A9E9882Q37023974-73DE5CDB-F445-466A-B20A-F4840A846FA4Q37038995-0BFA53AD-8175-48AA-876E-B262F2C1E580Q37105960-12E097B5-6228-44FC-957D-2E4C4773368CQ37505713-10B74F00-FB57-4802-839D-4750E2B2BDA0Q37603285-CCB95B26-22B5-49C0-BF13-C9CA21EE5A18Q37719289-E5945819-77C0-4F96-9FF2-1D86DCDEB185Q38103499-61501791-BC1F-4FE2-9A1E-EEE62EEE8798Q41407464-4C2DBD02-8344-445F-95FC-84130BE4EBE1Q42736779-98846CBC-8C77-4D70-96B2-D5D4662508EAQ44402305-9CA56DB4-BFA2-455A-BD17-2094959868BEQ44703995-EDAC5E65-BA0F-4540-9964-5DBFC04B001BQ47141461-6A653AB1-CCF6-400C-8B15-4917F92033D0Q47636471-DE638BB5-3A77-4F4E-ACEC-58AE409D122BQ47852087-723BE54C-8639-4123-98B5-424BBC1FA39FQ47978871-73C83E22-5861-4FF1-8103-C442815C6937Q48087273-32191E95-E630-42EA-8242-642BA93113AFQ48238095-9C532021-A707-4E4B-BA28-20076314474FQ52687706-F8161C44-C4E3-42B8-BE27-62C57FEC61A1
P2860
Stimulant therapy and seizure risk in children with ADHD.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Stimulant therapy and seizure risk in children with ADHD.
@en
Stimulant therapy and seizure risk in children with ADHD.
@nl
type
label
Stimulant therapy and seizure risk in children with ADHD.
@en
Stimulant therapy and seizure risk in children with ADHD.
@nl
prefLabel
Stimulant therapy and seizure risk in children with ADHD.
@en
Stimulant therapy and seizure risk in children with ADHD.
@nl
P2093
P1433
P1476
Stimulant therapy and seizure risk in children with ADHD.
@en
P2093
Pasternak JF
Trommer BL
P304
P356
10.1016/S0887-8994(00)00240-X
P577
2001-02-01T00:00:00Z